Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03142328
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
2EQ | 5-(5-chloro-2,4-dihydroxyphenyl)- N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole- 3-carboxamide | A | 2VCJ | 0.78 | |
2D7 | N-(4-ACETYLPHENYL)-5-(5-CHLORO- 2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE- 4-CARBOXAMIDE | A | 2BYH | 0.81 | |
2DD | 3-(5-CHLORO-2,4-DIHYDROXY-PHENYL)- 1H-PYRAZOLE-4-CARBOXYLIC ACID 4- SULFAMOYL-BENZYLAMIDE | A | 2BYI | 0.8 | |
4BH | 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H- PYRAZOL-5-YL)BENZENE-1,3-DIOL | A | 2CCS | 0.73 | |
2GJ | 5-[2,4-DIHYDROXY-5-(1-METHYLETHYL)PHENYL]- N-ETHYL-4-[4-(MORPHOLIN-4-YLMETHYL)PHENYL]ISOXAZOLE- 3-CARBOXAMIDE | A | 2VCI | 0.71 | |
FRH | 5-[2,3-DICHLORO-4-(5-{1-[2-(2-GUANIDINO- 4-METHYL-PENTANOYLAMINO)-ACETYL]- PIPERIDIN-4-YL}-1-METHYL-1H-PYRAZOL- 3-YL)-PHENOXYMETHYL]-FURAN-2-CARBOXYLIC ACID | A,B,C,D | 1PY2 | 0.71 | |
P4A | 4-[4-(4-methoxyphenyl)-5-methyl- 1H-pyrazol-3-yl]benzene-1,3-diol | A,B | 2ZDX | 0.77 | |
GNI | (3-{4-[2-(2,4-DICHLORO-PHENOXY)- ETHYLCARBAMOYL]-5-PHENYL-ISOXAZOL- 3-YL}-PHENYL)-ACETIC ACID | A,B | 2J14 | 0.72 | |
2E1 | 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)- N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE- 3-CARBOXAMIDE | A | 2CCT | 0.86 | |
CT5 | 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN- 6-YL)-3-METHYL-1H-PYRAZOL-5-YL]- 6-ETHYLBENZENE-1,3-DIOL | A | 2BRC | 0.72 | |
CT5 | 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN- 6-YL)-3-METHYL-1H-PYRAZOL-5-YL]- 6-ETHYLBENZENE-1,3-DIOL | A,B | 2CDD | 0.72 | |
CT5 | 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN- 6-YL)-3-METHYL-1H-PYRAZOL-5-YL]- 6-ETHYLBENZENE-1,3-DIOL | A,B | 2BT0 | 0.72 | |
BSM | 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)- N-ETHYL-4-(4-METHOXYPHENYL)-1H- PYRAZOLE-3-CARBOXAMIDE | A | 2BSM | 1 | |
FRI | 2-GUANIDINO-4-METHYL-PENTANOIC ACID [2- (4-{5-[4-(4-ACETYLAMINO-BENZYLOXY)- 2,3-DICHLORO-PHENYL]-2-METHYL-2H- PYRAZOL-3-YL}-PIPERIDIN-1-YL)-2- OXO-ETHYL]-AMIDE | A,B,C,D | 1QVN | 0.7 | |
CXZ | 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]- 1,2-benzisoxazol-3-yl}benzene-1,3- diol | A | 3BMY | 0.72 | |
76A | 3-(4'-HYDROXYBIPHENYL-4-YL)-N-(4- HYDROXYCYCLOHEXYL)-1,4-DIHYDROINDENO[1,2- C]PYRAZOLE-6-CARBOXAMIDE | A | 2E9N | 0.73 | |
KJ2 | 4-{4-[4-(3-AMINOPROPOXY)PHENYL]- 1H-PYRAZOL-5-YL}-6-CHLOROBENZENE- 1,3-DIOL | A,B | 2BRE | 0.82 | |
4BC | 4-(1,3-BENZODIOXOL-5-YL)-5-(5-ETHYL- 2,4-DIHYDROXYPHENYL)-2H-PYRAZOLE- 3-CARBOXYLIC ACID | A | 1YC3 | 0.77 | |
4BC | 4-(1,3-BENZODIOXOL-5-YL)-5-(5-ETHYL- 2,4-DIHYDROXYPHENYL)-2H-PYRAZOLE- 3-CARBOXYLIC ACID | A | 1YC1 | 0.77 | |
2D9 | 4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN- 1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3- DIOL | A | 2CCU | 0.71 | |
2GG | 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)- N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE- 3-CARBOXAMIDE | A | 2UWD | 0.85 |